Company Valuation: MedinCell S.A.

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 119.8 287.6 186.4 246.2 275.7 439 - -
Change - 140.1% -35.19% 32.11% 11.97% 59.24% - -
Enterprise Value (EV) 1 119.8 287.6 209.3 294.4 318.1 487.1 475.7 449.3
Change - 140.1% -27.23% 40.69% 8.03% 53.14% -2.33% -5.55%
P/E ratio -5.01x -13.6x -7.42x -7.72x -10.9x -23.1x 35.8x 9.82x
PBR - - -13.9x -5.86x -6.68x -8.84x 300x -
PEG - 0.5x -0.5x -0.3x 0.4x 0.9x -0x 0x
Capitalization / Revenue 42x 35.1x 45.6x 24.9x 30.5x 20.2x 11.2x 5.06x
EV / Revenue 42x 35.1x 51.2x 29.8x 35.2x 22.4x 12.1x 5.18x
EV / EBITDA - - -9.39x -13.2x -16.5x -40.9x 70x 8.93x
EV / EBIT -6.2x -18.7x -8.79x -12.3x -15.2x -63.2x 31.9x 9.08x
EV / FCF - - -9.1x -13.4x -24.3x -122x 94.5x 11.7x
FCF Yield - - -11% -7.48% -4.12% -0.82% 1.06% 8.52%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -1.19 -0.86 -1 -1.27 -0.88 -0.65 0.42 1.53
Distribution rate - - - - - - - -
Net sales 1 2.852 8.186 4.091 9.889 9.032 21.71 39.26 86.75
EBITDA 1 - - -22.3 -22.36 -19.26 -11.9 6.8 50.3
EBIT 1 -19.32 -15.37 -23.81 -24.02 -20.94 -7.706 14.9 49.5
Net income 1 -23.92 -19.02 -24.81 -29.5 -25.04 -16.09 9.967 44.7
Net Debt 1 - - 22.87 48.18 42.34 48.05 36.7 10.3
Reference price 2 5.96 11.70 7.42 9.81 9.59 15.02 15.02 15.02
Nbr of stocks (in thousands) 20,097 24,581 25,121 25,101 28,749 29,229 - -
Announcement Date 6/4/20 6/16/21 6/14/22 6/26/23 6/10/24 - - -
1EUR in Million2EUR
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (Y) EV / Sales (Y) EV / EBITDA (Y) Yield (Y) Capi.($)
-23.11x22.44x-40.93x-.--% 453M
70.58x17.84x49.86x0.6% 782B
22.44x7.93x15.45x2.25% 378B
22.27x4.31x12.58x3.09% 371B
43.21x7.05x16.25x3.27% 336B
15.4x3.76x9.3x3.42% 256B
27.23x4.64x14.65x2.14% 225B
16.62x4.18x10.11x3.57% 210B
32.28x6.26x11x3.06% 158B
15.2x3.25x8.19x6.44% 147B
Average 24.21x 8.17x 10.65x percentage-no-prefix 286.48B
Weighted average by Cap. 37.49x 8.83x 22.94x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. MEDCL Stock
  4. Valuation MedinCell S.A.